Compares treatment options for Splints
Official title Splinting vs Exercise in De Quervain's Tenosynovitis
ClinicalTrials.gov ID: NCT06995534
What this study is testing
- What it's testing
- De Quervain's disease is a painful tenosynovitis of the abductor pollicis longus and extensor pollicis brevis muscle tendons located in the first dorsal compartment. The primary treatment for De Quervain's disease is conservative; surgical intervention is rarely required.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adults aged between 18 and 65 years
- Patients experiencing wrist pain and tenderness for less than 3 months and clinically diagnosed with acute or subacute De Quervain's tenosynovitis
- Visual Analog Scale (VAS) pain score ≥ 3
You likely can't join if
- History of trauma
- Wrist fractures
- Local infection
- Presence of rheumatologic diseases (e.g., rheumatoid arthritis, psoriatic arthritis)
- Presence of symptomatic hand osteoarthritis
- Continuous use of nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids
See the full eligibility criteria
- Adults aged between 18 and 65 years
- Patients experiencing wrist pain and tenderness for less than 3 months and clinically diagnosed with acute or subacute De Quervain's tenosynovitis
- Visual Analog Scale (VAS) pain score ≥ 3
- History of trauma
- Wrist fractures
- Local infection
- Presence of rheumatologic diseases (e.g., rheumatoid arthritis, psoriatic arthritis)
- Presence of symptomatic hand osteoarthritis
- Continuous use of nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids
- Receipt of physical therapy for the hand or wrist within the past 3 months
- Corticosteroid injection into the hand or wrist within the past 3 months
- Diagnosed with significant neurological disorders (e.g., upper motor neuron disease)
- Presence of uncontrolled systemic diseases (e.g., uncontrolled diabetes mellitus, congestive heart failure, chronic kidney disease, hepatic failure)
- Major psychiatric disorders
- Communication difficulties
The study team makes the final eligibility decision.
Where it's taking place
- Konya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Konya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.